- Filed
- Apr 10, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 10, 2026 | 60.76M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 64.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 11.51M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$649.25K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$831.31K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.81K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $456.04K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $503.79M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $667.86M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.91M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.21M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.63M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $206.66K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $829.43K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $506.71M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $670.16M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.53 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.53 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $303K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$164.07M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$977.51K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.65M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$937.88K |